Consistently, BCL6 deficiency in B cells led to ~10-fold reduction in the percentage of Tfh and GC B cells in B-BCL6−/−–no-GVHD recipients as compared to B-BCL6+/+–no-GVHD recipients (Fig. 2f, g). This evidence concerns the gene BCL6 and graft versus host disease.